Understanding Geographic Atrophy and Wet AMD
What Is Geographic Atrophy?
Geographic atrophy (GA) is an advanced form of dry AMD that causes permanent damage to the light-sensing cells at the center of your eye. Understanding how it develops and what to watch for is the first step toward protecting your vision.
Your macula is the small central region of the retina responsible for sharp, detailed vision. In GA, the cells that make up the outer retina gradually die off in patches that expand over months to years. These patches have well-defined edges, which is why the condition is described as 'geographic.' The surrounding peripheral vision typically stays intact, but the center of what you see becomes increasingly blurry or blank as the patches grow.
Adults over age 60 face the greatest risk of developing GA, and that risk increases significantly after age 75. A family history of AMD raises your own chances, and smoking has been shown to roughly double the risk of AMD progression.
Additional factors that can increase your risk include:
- High blood pressure or cardiovascular disease
- A diet low in leafy green vegetables and antioxidants
- Light-colored eyes, such as blue or green
- Extended sun exposure without UV-protective eyewear
GA progresses slowly, and early changes can be subtle. You may first notice dim or blurry spots near the center of your vision, difficulty reading small print, or a need for brighter lighting during close-up tasks like cooking or sewing.
Colors may appear less vivid, and recognizing faces at a distance can become harder. Many people first notice these changes when reading in low light or performing detailed work. Because GA develops gradually, some patients adapt without realizing how much their vision has changed.
Our specialists use advanced imaging to find and measure areas of cell loss in the retina. Optical coherence tomography (OCT), which creates detailed cross-section images of the retina, allows your doctor to measure the thickness of each retinal layer and identify thinning caused by GA. Fundus autofluorescence photography highlights areas where cells have stopped functioning by detecting natural light emissions from retinal tissue.
These images are compared over time to track how quickly the damaged patches are growing. Regular monitoring allows your care team to adjust your plan based on what the images show at each visit.
What Is Wet AMD?
Wet AMD, also called neovascular AMD, is a distinct condition from GA that causes rapid central vision loss due to abnormal blood vessel growth. It requires urgent evaluation and treatment.
In wet AMD, the body responds to damaged retinal cells by growing new, fragile blood vessels beneath the retina. These vessels leak blood and fluid into the macula, disrupting the retinal layers that are responsible for central vision. Unlike GA, which progresses slowly over years, wet AMD can distort or destroy central vision within days or weeks.
The key warning signs of wet AMD are sudden and should never be ignored. Straight lines may appear wavy or bent. A dark or blank area may appear in the center of your vision. These changes can occur over hours or a few days, not gradually over months.
If you notice sudden visual distortion or a new dark spot in either eye, contact your eye doctor the same day. Prompt treatment gives you the best opportunity to preserve your remaining sight.
Your doctor will use OCT imaging to look for fluid pockets under or within the retina. Fluorescein angiography, a dye-based imaging test, can show exactly where abnormal blood vessels are leaking. During this test, a small amount of yellow dye is injected into a vein in your arm, and photographs are taken as the dye flows through the retinal blood vessels.
OCT angiography can also map the abnormal vessel network without the need for dye. Your doctor uses these tests together to determine how much fluid is present and where treatment should be focused.
How GA and Wet AMD Differ
While both GA and wet AMD affect the macula and cause central vision loss, they behave differently inside the eye and require different approaches to treatment. Knowing the key differences helps you understand what your doctor is looking for at each visit.
GA causes a slow, steady decline. The damaged patches may take years to expand into the very center of the macula, and many people with early GA retain functional reading vision for an extended period before daily activities are significantly affected.
Wet AMD works much faster. Fluid and blood from leaking vessels shift retinal cells out of position, causing sudden distortion or blind spots. Without treatment, severe central vision loss from wet AMD can occur within weeks.
In GA, retinal cells die and leave behind thin, pale patches of tissue. On imaging, your doctor sees well-defined areas where the retina has thinned, with no fluid or swelling involved in the process.
In wet AMD, abnormal blood vessels create fluid pockets and swelling under the retina. On imaging, your doctor sees elevated, irregular retinal layers rather than thin ones. The retina appears thickened and disrupted rather than atrophied.
Dry AMD can convert to wet AMD in some patients, though your doctor cannot predict when or whether this will happen. If you have dry AMD or GA, it is important to watch for sudden changes such as new distortion or a dark spot appearing in your vision.
You can monitor your own vision at home using an Amsler grid, a simple graph-paper-like chart. Cover one eye, look at the center dot, and note whether any lines appear wavy, bent, or missing. If they do, call your eye doctor right away. Catching wet AMD early gives treatment the best chance of working.
Treatment Options for GA and Wet AMD
Treatment approaches differ significantly between GA and wet AMD, and both conditions require ongoing care. Your doctor will explain which options apply to your situation based on your imaging results and overall eye health.
Two treatments for GA received FDA approval in 2023: pegcetacoplan and avacincaptad pegol. Both medications are injected directly into the eye on a regular schedule. Clinical trial data showed that both treatments slowed the growth of atrophic lesions, though neither restored vision that had already been lost. Your doctor may recommend one of these treatments to slow the rate of progression.
Both treatments carry an increased risk of converting dry AMD to wet AMD, so patients receiving either drug need regular monitoring for signs of new blood vessel growth. Your doctor will discuss whether the potential benefits outweigh this risk in your specific case.
Anti-VEGF (vascular endothelial growth factor) injections are the standard treatment for wet AMD. These medications are injected into the eye to block the signals that trigger abnormal blood vessel growth. Your eye is numbed with drops before the injection, and most patients feel pressure rather than sharp pain. The procedure itself takes only seconds.
Anti-VEGF therapy has been shown to stabilize vision in a large proportion of wet AMD patients and to improve vision in some. Most patients require injections every four to eight weeks at first. Over time, your doctor may extend the interval between injections if imaging shows that the retina remains free of fluid. Keeping your scheduled appointments is essential, because missing treatment can allow fluid to return and cause further vision loss.
The Age-Related Eye Disease Study 2 (AREDS2) identified a specific supplement formula that may slow progression from intermediate to advanced AMD in certain patients. The formula includes vitamins C and E, zinc, copper, lutein, and zeaxanthin. Your doctor will let you know whether this supplement is appropriate for your stage of AMD.
A diet rich in leafy green vegetables and fish also supports retinal health. Talk with your doctor before starting AREDS2 supplements, as the zinc levels in the formula can interact with some other medications.
Both GA and wet AMD require regular follow-up visits, even when vision feels stable. If you are receiving GA treatment, your doctor checks for signs of conversion to wet AMD at each visit. If you are receiving anti-VEGF injections for wet AMD, your doctor uses OCT imaging to monitor fluid levels and decide when your next injection is needed.
Consistent monitoring allows your care team to catch changes before you notice them in your daily life. Early detection of new or worsening findings gives you and your doctor more options to respond effectively.
Living with Advanced Macular Degeneration
When central vision declines, many tools and strategies can help you maintain independence and quality of life. Your eye care team can connect you with the right resources for your needs.
Magnifiers, screen readers, and electronic vision aids make it easier to continue reading, managing medications, and staying connected with others. Handheld or stand magnifiers work well for reading labels and mail. Electronic magnifiers allow you to enlarge text, adjust contrast, and customize brightness to suit your vision.
A low vision specialist can assess your specific needs and recommend devices that match your current level of vision. Many tools are available through vision rehabilitation programs, sometimes at little or no cost.
Improving lighting in your home makes a meaningful difference for people with AMD. Use focused task lighting for reading and cooking, and install nightlights in hallways and bathrooms to improve safety after dark.
Other practical changes include:
- High-contrast labels on appliances and medication bottles
- Bright tape along stair edges
- Large-button phones and talking clocks
- Decluttered walkways to reduce trip hazards
Managing AMD well involves collaboration between your eye doctor, low vision specialist, and, when appropriate, an occupational therapist. Ask your doctor about vision rehabilitation services in your area, as many states offer free or subsidized programs for people experiencing vision loss.
Keep all scheduled appointments even when your vision feels unchanged. Your doctor can often detect meaningful changes on imaging before you notice any new symptoms in daily life, and early action expands your available treatment options.
Frequently Asked Questions
These answers address common questions patients have after learning about GA and wet AMD, offering guidance that goes beyond what the sections above cover.
Yes, it is possible to have both conditions, either in the same eye or in different eyes. When this occurs, each condition is managed on its own schedule. GA treatment focuses on slowing lesion growth, while wet AMD requires anti-VEGF injections to control fluid from leaking blood vessels. Your doctor monitors each eye independently and tailors the plan accordingly.
Neither pegcetacoplan nor avacincaptad pegol can restore vision that GA has already taken away. These treatments work by slowing the rate at which damaged patches expand, not by rebuilding retinal cells that have already died. Starting treatment at an earlier stage, before patches reach the central macula, may help preserve more of your functional vision over time.
Whether you can safely and legally drive depends on how much central vision you have remaining and your state's specific licensing requirements. Your doctor can test your visual acuity and visual field to determine whether you currently meet those standards. Many patients with early-stage GA still qualify to drive, but your doctor will continue to evaluate this as your condition evolves and will advise you if that changes.
Delaying an injection can allow fluid to accumulate again beneath the retina, which may cause further damage to vision. If you need to reschedule, contact your doctor as soon as possible to minimize the gap in treatment. Repeated delays over time are associated with a greater risk of lasting vision loss that cannot be reversed even with resumed treatment, so staying on schedule is genuinely important.
Most major insurance plans, including Medicare, cover anti-VEGF injections when they are considered medically necessary for wet AMD. Coverage for the newer GA treatments varies by plan and may depend on your specific policy's formulary. It is worth asking your doctor's billing team to verify your benefits before starting any new treatment so you are not caught off guard by costs.
Most injection visits are completed in about 15 to 30 minutes from start to finish, including the time needed to prepare and numb the eye. The injection itself takes only a few seconds. Your eye may feel mildly irritated or look red for a day or two afterward, which is a normal response. Your doctor will tell you what to watch for and when to call if anything concerns you after the procedure.
See Our Retina Specialists at Rhode Island Eye Institute
If you have been diagnosed with AMD or have noticed changes in your central vision, our retina specialists, Dr. Gaurav Gupta and Dr. Pranjal Thakuria, are here to help you understand your condition and explore your options. Rhode Island Eye Institute brings together fellowship-trained subspecialists and advanced diagnostic technology so you receive expert, coordinated care from your very first visit. We welcome patients from across Rhode Island and southeastern Massachusetts, and we are committed to helping you protect the vision that matters most to you.